Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
180 Life Sciences ( (ATNF) ) has shared an update.
On July 24, 2025, 180 Life Sciences held its Annual Meeting where stockholders approved several key proposals, including an amendment to increase the company’s authorized shares of common stock from 100 million to 1 billion. This strategic move, effective immediately upon filing, aims to provide the company with greater flexibility in its financial operations and potential growth opportunities. Additionally, the meeting saw the election of two Class I directors and the approval of various management proposals, including incentive plans and executive compensation, indicating a strong shareholder backing for the company’s strategic direction.
More about 180 Life Sciences
Average Trading Volume: 1,710,518
Technical Sentiment Signal: Buy
Current Market Cap: $13.83M
For a thorough assessment of ATNF stock, go to TipRanks’ Stock Analysis page.